Trifast (TRI) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
3 Jul, 2026Executive summary
Achieved strong FY 2025 performance and significant earnings growth, driven by strategic self-help initiatives in margin management, focused growth, operational efficiency, and organizational effectiveness.
Delivered 300 basis points improvement in gross margin and increased EBIT margin to 6.8%, with a 30% rise in EBIT to GBP 15.6 million.
Completed the recover phase of transformation, achieving £3m in annualized cost savings and strengthening the balance sheet.
Maintained dividends at prior year levels to support long-term growth and margin enhancement.
Focused on three core markets: automotive, smart infrastructure, and medical equipment, with notable progress in smart infrastructure.
Financial highlights
Revenue for FY 2025 was GBP 227.4 million, a 4.4% decline year-over-year, mainly due to the sale of the Norwegian operation and exit from low-margin customers.
Gross margin rose by 300 basis points to 28.4%; EBIT increased 30% to GBP 15.6 million, with EBIT margin at 6.8%.
Underlying profit before tax increased by 69%; underlying diluted EPS doubled to GBP 0.0431.
Achieved GBP 3 million in annualized savings from operational improvements.
Net debt reduced to GBP 17.4 million, leverage below 1.0x EBITDA, and cash conversion at 100.2%.
Outlook and guidance
FY 2026 faces significant macroeconomic headwinds, including U.S. trade tariffs and a weakening U.S. dollar.
Q1 FY 2026 revenues are behind expectations, especially in automotive.
Confident in continued margin growth and on track to achieve medium-term double-digit EBIT margin target.
FY26 priorities include margin management, focused growth in US and Asia, operational efficiency, and organisational effectiveness.
Actively pursuing bolt-on acquisitions in target markets and regions.
Latest events from Trifast
- Margin and cash gains offset revenue decline, with growth led by smart infrastructure and digital investment.TRI
H2 20263 Jul 2026 - Underlying EBIT margin rose to 7.9% as margin management offset revenue decline and sector headwinds.TRI
H2 20262 Jul 2026 - Margin gains and strategic shifts offset revenue drop, supporting medium-term EBIT targets.TRI
H2 2026 TU29 Apr 2026 - On track for FY26 expectations, focusing on margin improvement amid tough market conditions.TRI
Q3 2026 TU12 Feb 2026 - Strong financial recovery, strategic sector pivot, and all AGM resolutions approved.TRI
AGM 20253 Feb 2026 - EBIT margin improved and net debt fell sharply as focus shifts to double-digit margins and key growth sectors.TRI
H2 20242 Feb 2026 - Margins and ROCE improved despite revenue decline, with outlook and guidance maintained.TRI
H1 202620 Nov 2025 - Gross margin and ROCE improved despite revenue decline; margin targets reaffirmed.TRI
H1 202618 Nov 2025 - Margins and profits improved despite lower revenue, with net debt sharply reduced.TRI
H1 202513 Jun 2025